IMP
Process View
cytoplasmic pattern recognition receptor signaling pathway
Any series of molecular signals generated as a consequence of a cytoplasmic pattern recognition receptor (PRR) binding to one of its physiological ligands. PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species, or damage-associated molecular pattern (DAMPs), endogenous molecules released from damaged cells.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cytoplasmic pattern recognition receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| nfkbiab | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha b | 0.820 | Mouse | |
| nfkbiaa | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha a | 0.659 | Mouse | |
| nod1 | nucleotide-binding oligomerization domain containing 1 | 0.587 | ||
| LOC557072 | caspase recruitment domain-containing protein 11-like | 0.383 | ||
| rel | v-rel reticuloendotheliosis viral oncogene homolog | 0.136 | ||
| comta | catechol-O-methyltransferase a | 0.103 | ||
| cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.101 | ||
| gadd45ba | growth arrest and DNA-damage-inducible, beta a | 0.097 | ||
| cav1 | caveolin 1 | 0.072 | ||
| btg2 | B-cell translocation gene 2 | 0.051 | ||
| socs3a | suppressor of cytokine signaling 3a | 0.046 | ||
| dhfr | dihydrofolate reductase | 0.044 | ||
| si:dkey-236e20.2 | si:dkey-236e20.2 | 0.043 | ||
| klf2a | Kruppel-like factor 2a | 0.037 | ||
| card9 | caspase recruitment domain family, member 9 | 0.035 | ||
| tcf21 | transcription factor 21 | 0.034 | ||
| sp2 | sp2 transcription factor | 0.034 | ||
| vtg6 | vitellogenin 6 | 0.033 | ||
| dusp1 | dual specificity phosphatase 1 | 0.030 | ||
| phox2b | paired-like homeobox 2b | 0.028 | ||
| junb | jun B proto-oncogene | 0.025 | ||
| efna2 | ephrin A2 | 0.025 | ||
| lndc1 | ly6/neurotoxin domain containing 1 | 0.024 | ||
| pycard | PYD and CARD domain containing | 0.021 | ||
| stc1l | stanniocalcin 1, like | 0.021 | ||
| gfer | growth factor, augmenter of liver regeneration (ERV1 homolog, S. cerevisiae) | 0.021 | ||
| itm2bb | integral membrane protein 2Bb | 0.020 | ||
| LOC100000332 | e3 ubiquitin-protein ligase RNF182-like | 0.019 | ||
| atf3 | activating transcription factor 3 | 0.019 | ||
| ighm | immunoglobulin heavy constant mu and immunoglobulin heavy constant mu | 0.018 | ||
| cebpd | CCAAT/enhancer binding protein (C/EBP), delta | 0.018 | ||
| jun | jun proto-oncogene | 0.017 | ||
| wnt9a | wingless-type MMTV integration site family, member 9A | 0.017 | ||
| plekhf1 | pleckstrin homology domain containing, family F (with FYVE domain) member 1 | 0.017 | ||
| mcl1a | myeloid cell leukemia sequence 1a | 0.017 | ||
| sult3st1 | sulfotransferase family 3, cytosolic sulfotransferase 1 | 0.016 | ||
| LOC100331484 | hypothetical protein LOC100331484 | 0.015 | ||
| ctssb.2 | cathepsin S, b.2 | 0.015 | ||
| zgc:66382 | zgc:66382 | 0.014 | ||
| fos | v-fos FBJ murine osteosarcoma viral oncogene homolog | 0.013 | ||
| st8sia1 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 | 0.013 | ||
| si:ch211-195h23.3 | si:ch211-195h23.3 | 0.013 | ||
| mcl1b | myeloid cell leukemia sequence 1b | 0.013 | ||
| phlda2 | pleckstrin homology-like domain, family A, member 2 | 0.013 | ||
| hoxa13a | homeo box A13a | 0.012 | ||
| lrmp | lymphoid-restricted membrane protein | 0.012 | ||
| nrp1b | neuropilin 1b | 0.012 | ||
| sb:cb252 | sb:cb252 | 0.012 | ||
| sult3st2 | sulfotransferase family 3, cytosolic sulfotransferase 2 | 0.011 | ||
| arrdc2 | arrestin domain containing 2 | 0.011 | ||
| rnf128a | ring finger protein 128a | 0.011 | ||
| arl5c | ADP-ribosylation factor-like 5C | 0.011 | ||
| dab1b | disabled homolog 1b (Drosophila) | 0.011 | ||
| fkbp5 | FK506 binding protein 5 | 0.010 |